Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

AIMS: It is recommended to perform atrial fibrillation ablation with continuous anticoagulation. Continuous apixaban has not been tested. METHODS AND RESULTS: We compared continuous apixaban (5 mg b.i.d.) to vitamin K antagonists (VKA, international normalized ratio 2–3) in atrial fibrillation patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Kirchhof, Paulus, Haeusler, Karl Georg, Blank, Benjamin, De Bono, Joseph, Callans, David, Elvan, Arif, Fetsch, Thomas, Van Gelder, Isabelle C, Gentlesk, Philip, Grimaldi, Massimo, Hansen, Jim, Hindricks, Gerhard, Al-Khalidi, Hussein R, Massaro, Tyler, Mont, Lluis, Nielsen, Jens Cosedis, Nölker, Georg, Piccini, Jonathan P, De Potter, Tom, Scherr, Daniel, Schotten, Ulrich, Themistoclakis, Sakis, Todd, Derick, Vijgen, Johan, Di Biase, Luigi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Fast Track Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6110196/
https://ncbi.nlm.nih.gov/pubmed/29579168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehy176
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars